Drug-Induced Liver Injury From Chinese, Western Meds Varies

This article originally appeared here.
Share this content:
Drug-Induced Liver Injury From Chinese, Western Meds Varies
Drug-Induced Liver Injury From Chinese, Western Meds Varies

MONDAY, Feb. 29, 2016 (HealthDay News) -- Chinese herbal medicine (CHM) and Western medicine (WM) have different effects as causes of drug-induced liver injury (DILI), according to a study published online Feb. 20 in the Journal of Gastroenterology and Hepatology.

Yun Zhu, from the China Military Institute of Chinese Medicine in Beijing, and colleagues examined the differences between CHM and WM as agents implicated in liver injury using data from 1,985 DILI cases collected from 96,857 patients hospitalized due to liver dysfunction in a military hospital. Of the patients enrolled with DILI, CHM was implicated in 28.4 percent of cases, WM in 43.8 percent of cases, and the combination of WM and CHM in 27.8 percent of cases.

The researchers found that the major implicated CHM was Polygonum multiflorum. Cases caused by CHM more frequently occurred in females (71 versus 51 percent; P < 0.001) and had a higher percentage of positive rechallenge (8.9 versus 6.1 percent; P = 0.046) than WM. CHM was also responsible for a greater proportion of cases with hepatocellular injury (88.5 versus 62.2 percent; P < 0.001) and higher mortality (4.8 versus 2.8 percent; P = 0.042). Overall, 75.6 and 16.6 percent of cases caused by CHM were classified as probable and highly probable, respectively, compared with 38.4 and 60.3 percent for WM (P < 0.001).

"There is a need for multicenter and prospective researches to investigate herbal hepatotoxicity and to find the distinctive characteristics of DILI caused by CHM," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »